BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8336048)

  • 1. [Long-term results of isolated mitral valve replacement using bioprosthesis].
    Yao H; Miyamoto T; Murata H
    Nihon Kyobu Geka Gakkai Zasshi; 1993 Jun; 41(6):969-74. PubMed ID: 8336048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An eight-year experience with porcine bioprosthetic cardiac valves.
    Hartz RS; Fisher EB; Finkelmeier B; DeBoer A; Sanders JH; Moran JM; Michaelis LL
    J Thorac Cardiovasc Surg; 1986 Jun; 91(6):910-7. PubMed ID: 3713240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early mechanical failures of the Hancock pericardial xenograft.
    Bortolotti U; Milano A; Thiene G; Guerra F; Mazzucco A; Valente M; Talenti E; Gallucci V
    J Thorac Cardiovasc Surg; 1987 Aug; 94(2):200-7. PubMed ID: 3613618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Necessity of permanent anticoagulant therapy for isolated mitral valve replacement with bioprosthetic heart valve to prevent the postoperative thromboembolic complications].
    Yao H; Miyamoto T; Yamashita K; Mukai M; Wada T; Yamamura M; Nakagawa T; Ryomoto M
    Kyobu Geka; 2000 Apr; 53(4):337-40. PubMed ID: 10770064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aortic valve replacement with the Hancock standard, Björk-Shiley, and Lillehei-Kaster prostheses. A comparison based on follow-up from 1 to 15 years.
    Milano AD; Bortolotti U; Mazzucco A; Guerra F; Magni A; Gallucci V
    J Thorac Cardiovasc Surg; 1989 Jul; 98(1):37-47. PubMed ID: 2739424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valve-related complications with the Hancock I porcine bioprosthesis. A twelve- to fourteen-year follow-up study.
    Bernal JM; Rabasa JM; Cagigas JC; Echevarria JR; Carrion MF; Revuelta JM
    J Thorac Cardiovasc Surg; 1991 May; 101(5):871-80. PubMed ID: 2023444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Carpentier-Edwards standard porcine bioprosthesis. A first-generation tissue valve with excellent long-term clinical performance.
    Jamieson WR; Allen P; Miyagishima RT; Gerein AN; Munro AI; Burr LH; Tyers GF
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):543-61. PubMed ID: 2308373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the Carpentier-Edwards porcine bioprosthesis: assessment of a patient selection policy.
    Louagie Y; Noirhomme P; Aranguis E; Eucher P; Vanruyssevelt P; Buche M; Dion R; Jaumin P; Schoevaerdts JC; Chalant CH
    J Thorac Cardiovasc Surg; 1992 Oct; 104(4):1013-24. PubMed ID: 1405658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twelve-year experience with the 19 mm Carpentier-Edwards pericardial aortic valve.
    Nakajima H; Aupart MR; Neville PH; Sirinelli AL; Meurisse YA; Marchand MA
    J Heart Valve Dis; 1998 Sep; 7(5):534-9. PubMed ID: 9793853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience.
    Goldsmith I; Lip GY; Mukundan S; Rosin MD
    J Heart Valve Dis; 1998 Sep; 7(5):574-9. PubMed ID: 9793859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Hancock II porcine bioprosthesis. A preliminary report.
    Bortolotti U; Milano A; Mazzucco A; Guerra F; Magni A; Santini F; Gallucci V
    J Thorac Cardiovasc Surg; 1989 Mar; 97(3):415-20. PubMed ID: 2918737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term clinical results with the Ionescu-Shiley pericardial xenograft.
    Masters RG; Pipe AL; Bedard JP; Brais MP; Goldstein WG; Koshal A; Keon WJ
    J Thorac Cardiovasc Surg; 1991 Jan; 101(1):81-9. PubMed ID: 1986173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1,000 patients.
    McClure RS; Narayanasamy N; Wiegerinck E; Lipsitz S; Maloney A; Byrne JG; Aranki SF; Couper GS; Cohn LH
    Ann Thorac Surg; 2010 May; 89(5):1410-6. PubMed ID: 20417753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term evaluation of the Carpentier-Edwards pericardial bioprosthesis].
    Takahara Y; Sudou Y; Murayama H; Nakamura T
    Nihon Kyobu Geka Gakkai Zasshi; 1995 Aug; 43(8):1097-102. PubMed ID: 7594841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart valve replacement--a report of 8- to 17-year follow-up.
    Kimura M; Kitasato K; Kamatani M
    Igaku Kenkyu; 1992 Apr; 62(2):57-64. PubMed ID: 1523944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seventeen-year experience with the St. Jude medical biocor porcine bioprosthesis.
    Mykén PS
    J Heart Valve Dis; 2005 Jul; 14(4):486-92. PubMed ID: 16116875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aortic and mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 10-year results.
    Murakami T; Eishi K; Nakano S; Kobayashi J; Sasako Y; Isobe F; Kosakai Y; Kito Y; Kawashima Y
    J Heart Valve Dis; 1996 Jan; 5(1):45-9. PubMed ID: 8834725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term results of porcine bioprosthetic heterograft; a 13-years' experience].
    Sawatani KA; Nakano K; Imamura E; Endo M; Hashimoto A; Hayashi H; Koyanagi H
    Nihon Geka Gakkai Zasshi; 1988 Nov; 89(11):1886-92. PubMed ID: 3205254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Durability of porcine valves at fifteen years in a representative North American patient population.
    Burdon TA; Miller DC; Oyer PE; Mitchell RS; Stinson EB; Starnes VA; Shumway NE
    J Thorac Cardiovasc Surg; 1992 Feb; 103(2):238-51; discussion 251-2. PubMed ID: 1735989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival and bioprosthetic valve failure. Ten-year follow-up.
    Teoh KH; Ivanov J; Weisel RD; Darcel IC; Rakowski H
    Circulation; 1989 Sep; 80(3 Pt 1):I8-15. PubMed ID: 2766540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.